Recognition of biased immunoglobulin variable (IgV) gene usage in B-cell chronic lymphocytic leukemia (B-CLL) may yield insight into leukemogenesis and may help to refine prognostic categories. We explored Ig variable heavy (V H ) and light (V L ) chain gene usage in highly stable and indolent B-CLL (n ¼ 25) who never required treatment over 10 or more years. We observed an unexpectedly high usage of mutated V H 3-72 (6/25; 24.0%), a gene that was otherwise rare in B-CLL (7/805; 0.87%; Po0.01), including mutated cases (6/432; 1.39%; Po0.01) and was exceptional among indolent (1/230, 0.435%; Po0.01), and aggressive B-cell lymphomas (0/105; Po0.01). Three of six V H 3-72 B-CLL cases utilized the same V L V j 4-1 gene. Two V H 3-72 B-CLL cases had highly homologous V H complementarity determining regions 3 (CDR3s), encoding Cys-XXXX-Cys domains, and utilized V j 4-1 genes with homologous IgV L CDR3s. An identical threonine to isoleucine change at codon 84 of V H 3-72 framework region 3 (FR3) recurred in four cases of highly stable V H 3-72 B-CLL. This mutation is expected to cause a conformational change of FR3 proximal to CDR3 that might critically affect high-affinity antigen binding. B-cell receptors encoded by V H 3-72 may identify a specific B-CLL group and be implicated in leukemogenesis through an antigen-driven expansion of B cells.
Introduction
B-cell chronic lymphocytic leukemia (B-CLL), the most common leukemia type in the Western hemisphere, may be dissected into at least two clinico-pathologic variants based on somatic hypermutation (SHM) of immunoglobulin variable (IgV) genes, the presence of mutations favoring prolonged survival. 1, 2 The expression level of ZAP-70 and, to a lesser extent, of CD38 is correlated with the Ig SHM status. 1, 3 Within the two major categories of IgV mutated and unmutated B-CLL, disease heterogeneity may be further refined by usage of specific IgV heavy (V H ) and light (V L ) chain genes. [4] [5] [6] To date, several groups of B-CLL displaying a biased usage of IgV genes have been identified among both mutated and unmutated cases. [7] [8] [9] [10] [11] In some instances, restriction of B-cell receptor (BCR) usage in B-CLL may have prognostic significance independent of the IgV mutational status. 10 Remarkably, extensive analysis of complementarity determining regions 3 (CDR3s) of V H and V L chains has revealed that a fraction of B-CLL is characterized by a high degree of BCR homology. [12] [13] [14] [15] As biased IgV usage and BCR homology suggest selection for a particular reactivity implicated in B-cell expansion, the recognition of these IgV features in some B-CLL groups may shed light on leukemogenesis. [4] [5] [6] 16 Analysis of V H and V L genes V H and V L rearrangements were amplified from genomic DNA using Taq polymerase with family-specific primers hybridizing to leader or framework (FR) 1 sequences and J H , J k or J l degenerate primers. 8, [18] [19] [20] [21] For IgV sequencing, a DNA direct sequencing approach was utilized in all cases. 21 Sequences were analyzed as reported 21 and considered mutated if deviation from the closest germline gene was X2%. Criteria for D element identification in CDR3 were as reported. 22 DIR segments and 'minor' D segments were not considered. 23 V H CDR3 length was determined according to Kabat et al 24 by counting the amino-acid (aa) number between position 94 at the end of FR3 (usually two aa downstream of the conserved cysteine) and position 102 at the beginning of FR4 (a conserved tryptophan in all J H segments). The length of V L CDR3 was determined by counting the number of aa between position 88 at the end of FR3 and position 97 at the beginning of FR4 (a conserved phenylalanine in all J L segments). IgV CDR3 charge, defined by an estimated isoelectric point (pI), was determined using the MacVector software.
Statistical analysis
Data of V H and V L rearrangements, VDJ usage, mutation frequencies, CDR3 length and pI were handled in Excel spreadsheet format (Microsoft Corp, Redmond, WA, USA). SPSS Table 1 References and other sources used for the construction of the IgV database 
Nonrandom V L rearrangements in highly stable B-CLL
A clonal productive V L rearrangement could be identified in all but one highly stable B-CLL (Table 2 ). In one case (case 17), only the rearrangement of a nonfunctional allele of the V k 2-29 locus was found. Overall, 19/25 (76.0%) highly stable B-CLL Table 2 General characteristics of V H and V L productive rearrangements in highly stable B-CLL CDR, complementarity determining region; FR, framework region; P is the probability calculated to evaluate whether the excess or the scarcity of R mutations in CDR and FR, respectively, is due to chance alone; P B , P-value calculated according to the binomial distribution model; P M , P-value calculated according to the multinomial distribution model; Bold values represent P-values o0.05.
Biased IgV usage in highly stable B-CLL D Capello et al displayed mutations in V L genes, with an average mutation frequency, among mutated cases, of 4.4771.39%, median 4.68%, range 2.11-6.84%. A total of 22 cases rearranged a V k family gene (Table 2) . Three cases rearranged a V l family gene (cases 10, 13, 14) . Among cases rearranging a V k gene, the V k family most frequently used was V k 1 (13/22; 59.1%), followed by V k 3 (4/22; 18.20%), V k 4 (3/22; 13.6%) and V k 2 (3/22; 13.6%). The most frequently used V k gene was V k 1-5 (8/22; 36.4%), followed by V k 4-1 (3/22; 13.6%), V k 2-28, V k 3-15 and V k 3-20 (2/19; 10.5% for each gene). Usage of V k 1-5 in highly stable B-CLL appeared to be significantly higher compared to that of B-CLL from the database and of normal B cells (Po0.01). 33, 34 All V H 3-72 B-CLL used V k family genes ( Table 2 and Figure 2 ). Remarkably, three of six V H 3-72 B-CLL (cases 3, 5, 6) utilized the same V k gene (V k 4-1), which did not occur in the other highly stable cases. Two additional cases (cases 2 and 4) of V H 3-72 B-CLL used the V k 1-5 gene.
Mutational hotspots in V H 3-72 genes of highly stable B-CLL V H 3-72 genes of highly stable B-CLL exhibited a C4T mutational hotspot at codon 84 of FR3 causing the substitution of isoleucine for threonine in 4/6 (66.7%) cases (Figure 1 ). This change was restricted to 2/22 (9.09%; Po0.01) mutated V H 3-72 rearrangements of non-neoplastic B cells derived from public databases, despite the location of codon 84 within a WRCY hotspot. Since this mutation substitutes a hydrophobic for a polar residue, it is expected to cause a conformational change of FR3 proximal to CDR3 that might critically affect high-affinity antigen binding. V H 3-72 genes of highly stable B-CLL displayed another mutational hotspot at codon 51, also C4T, again causing the substitution of isoleucine for threonine in 4/6 (66.7%) cases (Figure 1 ). This substitution was not selective for highly stable B-CLL, being found in 9/22 (40.9%) V H 3-72 sequences of non-neoplastic B cells derived from public databases. These recurrent mutations are unlikely to be germline polymorphisms, because no allelic variation was seen in three independent sequences of V H 3-72 germline genes (GenBank accession numbers X92206, AF538057, NG_001019). 35, 36 Moreover, the somatic origin of mutations was formally demonstrated in one case of V H 3-72 B-CLL, which, by DNA direct sequencing, displayed the mutations in the lymphocyte DNA, but not in the corresponding granulocyte DNA.
Distribution of IgV mutations in highly stable B-CLL
Mutation distribution between CDR and FR in both V H and V L utilized by highly stable B-CLL was evaluated by the ChangCasali binomial and multinomial distribution models. 25, 26 Cases were scored as positive for clustering of silent mutations in FR if the P-value was significant in either V H or V L genes or both. Similarly, cases were scored as positive for clustering of replacement mutations in CDR if the P-value was significant in either V H or V L genes or both. Results are summarized in Case 3 ....T.....................T........C..................... ..G....T...T..............G....G....T...........................T.........................A..... .  Case 4 ....T......T......G...T.............................G.... ............................................CG.G................................. ..A........................... .......GG...........C...........................................T.............C....C......A 
CDR3 analysis in highly stable B-CLL
Use of J H and J k genes in highly stable B-CLL was consistent with that found in B-CLL from the database and in non-neoplastic B cells. 29, 33, 34 (See also Table 2 .) The most J-proximal D7-27 (DHQ52) D element was over-represented (Po0.05) in highly stable mutated B-CLL (3/13; 23.1%) compared to mutated B-CLL from the database (1/148; 0.676%) and non-neoplastic B cells. 29, 37, 38 The mean CDR3 length of highly stable B-CLL (13.373.91 codons) was not different from that of mutated B-CLL from the database (13.672.26 codons) ( Table 3) .
Cluster analysis revealed that two V H 3-72 B-CLL (cases 5 and 6 in Table 3 and Figure 1 ) had highly homologous V H CDR3 aa sequences, differing only by conservative substitutions. Both cases rearranged the same D segment (D2-2, in the same reading frame) and the same J H gene (J H 3). Both these V H 3-72 cases also utilized V k 4-1 genes and displayed a highly homologous V L CDR3, differing only by one conservative change (Table 3 and Figure 2) .
Consistent with previous reports in B-CLL, 8 the estimated pI value of V H CDR3 was acidic in the majority (19/25; 76.0%) of highly stable B-CLL (Table 3 ). The estimated pI value was basic in 4/25 (16.0%) cases, including two V H 3-72 B-CLL with highly homologous CDR3 (cases 5 and 6 in Table 3 ).
Discussion
In this study, we describe the biased usage of specific V H and V L genes and the CDR3 features in a series of clinically highly stable B-CLL cases, which did not progress or require treatment during a follow up of X10 years. The data reveal that usage of V H 3-72 and V H 2-05 genes is significantly higher in highly stable B-CLL patients compared to B-CLL from published databases, non-neoplastic B cells or other B-cell lymphoproliferative disorders. Among V L genes, highly stable B-CLL display a favored usage of V k 1-5 and V k 4-1 genes compared to B-CLL from the database and non-neoplastic B-cells. Notably, two cases of highly stable B-CLL displayed highly homologous CDR3s both in V H and V L genes. These data expand on the emerging knowledge of a BCR restriction in B-CLL and document that this phenomenon is a characteristic of the disease also in highly stable cases. GGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGATTTCACTCTCACCATCAGCAGCCTGCAGCCTGAAGATTTTGCAACTTATTACTGC CAACAGTATAATAGTTACCC GATCACC TTCGGCCAAGGG  Case 1 ................................................................................................ .G...C. Case 2 ..............................................................................A................T  Case 4 ............................................T...............T................................... . ........C............ .........................................C...................A..................................  Case 5 ........A............ ..................... ................................................................................................  Case 6 ..................... ..................... ........................................................................................... Recent studies have shown that a restricted usage of specific V H and V L genes is a frequent feature of B-CLL, and that B-CLL cells utilizing a particular V H gene preferentially associate with specific V L genes. [7] [8] [9] [10] [11] [12] [13] [14] [15] Although most examples of BCR restriction have been described in IgV unmutated B-CLL, [7] [8] [9] [10] [11] [12] [13] [14] [15] this and other reports document that BCR restriction may be a feature also of IgV-mutated B-CLL. 10, 12, 14 Whereas past examples of BCR restriction in B-CLL have all been associated with poor prognosis, 10,13 our study points to IgV genes that are preferentially utilized by B-CLL with a very good outcome.
_____________________________________________FR3________________________________________________ vk1-5 GGGGTCCCATCAAGGTTCAGCGGCAGTGGATCTGGGACAGAATTCACTCTCACCATCAGCAGCCTGCAGCCTGATGATTTTGCAACTTATTACTGC

______________CDR3____________ _________JK4________
CAACAGTATAATAGTTATTCTC GCTCACT TTCGGCGGAGGG
Remarkably, highly stable B-CLL patients display a biased usage of V H 3-72 even when the comparison is restricted to the group of IgV-mutated B-CLL from the database, to which highly stable B-CLL belong. In this respect, it should be noted that highly stable B-CLL are patients who never required any treatment over a follow-up period of X10 years and for whom, consequently, the definition of highly stable B-CLL is more restrictive than that of IgV-mutated B-CLL. Indeed, only a fraction of mutated cases display a highly stable clinical behavior matching the criteria adopted in our study.
Alignment analysis of V H and V L CDR3s revealed the presence of two V H 3-72 B-CLL with highly homologous V H CDR3s differing only by conservative substitutions. The CDR3 of these two cases included a Cys-XXXX-Cys domain, allowing for the formation of a disulfide bridge. Also, both these V H 3-72 cases utilized V k 4-1 genes displaying highly homologous V L CDR3s. The highly restricted and homologous structure of BCR strongly suggests selection for a specific reactivity in these cases of highly stable B-CLL. This hypothesis is also supported by selection of hotspot aa substitutions located in the FR3, which recurred in both cases of V H 3-72 B-CLL displaying homologous CDR3s. The nonrandom nature of the CDR3 homology observed in V H 3-72 B-CLL is suggested by the very low probability of finding two clones with highly homologous V H and V L rearrangements by chance alone in the same disease subset. Based on the potential number of V H , D, J H , V L and J L genes that could combine to form a functional BCR, one would expect that B cells would randomly express the same V H and V L genes at a probability lower than 10 À6 . This estimate does not take into account junctional diversity, which would decrease the probability to less than 10
À12
. The biased usage of V H and V L genes in highly stable B-CLL may be the consequence of neoplastic expansion of B cells derived from a normal B-cell subset characterized by reduced BCR heterogeneity before transformation, or, alternatively, expansion of B cells selected by antigen at some stage of disease development. Independent of the mechanism leading to biased V H and V L usage in highly stable B-CLL, it is conceivable that selection of specific BCR structures may affect the growth and evolution of the leukemic clone.
A large-scale analysis of IgV gene rearrangements in highly stable B-CLL patients is required to completely exclude the possibility that the BCR restriction observed in our series might reflect a geographical bias. Finally, if our finding that V H 3-72 is largely restricted to highly stable cases proves true in a broader patient population, its detection may contribute to the prognostic stratification at the time of disease presentation. a Positively charged residues are italicized and underlined; negatively charged residues are represented in bold type.
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